Next-Generation Diabetes-Managing Innovations : ReShape Lifeciences
ReShape Lifesciences has secured a $241,000 supplementary grant from the NIH to advance the development of its Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system, a device aimed at managing Type 2 diabetes. The grant will support further preclinical trials using the DBSN™ device, including the development of next-generation electrodes to improve treatment efficacy and reduce power consumption. […]
